Literature DB >> 3496655

Plasma bone Gla protein concentrations in healthy adults. Dependence on sex, age, and glomerular filtration.

J S Johansen, K Thomsen, C Christiansen.   

Abstract

Plasma bone Gla protein (BGP) was determined by radio-immunoassay in 266 healthy adults, men (n = 132) and women (n = 134), aged 20-79 years. In the women aged 30-69 years, plasma BGP increased significantly with age (r = 0.44, p less than 0.001), and a particularly steep increase was seen from 1.1 +/- 0.5 (mean +/- 1 SD) in the fifth decade to 2.0 +/- 1.4 nmol/l in the seventh decade. In men, aged 30-69 years, no correlation was found between plasma BGP and age (r = -0.07, NS). Plasma bone Gla protein is removed from the circulation mainly by the kidneys and the increased plasma BGP in the women could be caused by decreased renal clearance. The interrelationship was analysed by means of partial correlation. When creatinine clearance was held constant in women, BGP still correlated positively with age (r = 0.40, p less than 0.001), but not with creatinine clearance (r = 0.003, NS) when age was fixed. Plasma BGP was significantly increased above normal in 35 patients with chronic renal failure (10.2 +/- 14.6 nmol/l). Non-linear regression analysis showed that plasma BGP was within the normal range when 24-h creatinine clearance was greater than 30 ml/min, and large increases in plasma BGP did not occur until the 24-h creatinine clearance was below 20 ml/min. We conclude that, in normal subjects and patients with mild to moderate renal failure, plasma elevations of BGP reflect increased bone turnover rather than decreased renal clearance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496655     DOI: 10.1080/00365518709168912

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  7 in total

1.  Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium citrate administered over the short-, medium- and long-term medication of male stone patients.

Authors:  P O Schwille; U Herrmann; C Wolf; I Berger; R Meister
Journal:  Urol Res       Date:  1992

2.  Diurnal rhythm and 24-hour integrated concentrations of serum osteocalcin in normals: influence of age, sex, season, and smoking habits.

Authors:  H K Nielsen; K Brixen; L Mosekilde
Journal:  Calcif Tissue Int       Date:  1990-11       Impact factor: 4.333

Review 3.  Use of non-collagen markers in osteoporosis studies.

Authors:  M T Parviainen; A Pirskanen; A Mahonen; E M Alhava; P H Mäenpää
Journal:  Calcif Tissue Int       Date:  1991       Impact factor: 4.333

4.  Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium sodium citrate administered as short-, medium- and long-term to male stone patients.

Authors:  U Herrmann; P O Schwille; H Schwarzlaender; I Berger; G Hoffmann
Journal:  Urol Res       Date:  1992

5.  Osteocalcin in patients with rheumatoid arthritis--effect of anatomical stages, inflammatory activity and therapy.

Authors:  H Franck; T H Ittel; O Tasch; G Herborn; R Rau
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

6.  Assessment of age and risk factors on bone density and bone turnover in healthy premenopausal women.

Authors:  M A Hansen
Journal:  Osteoporos Int       Date:  1994-05       Impact factor: 4.507

7.  Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients.

Authors:  T Saarto; C Blomqvist; J Risteli; L Risteli; S Sarna; I Elomaa
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.